Objective-Vascular calcification significantly increases morbidity in life-threatening diseases, and no treatments are available because of lack of understanding of the underlying molecular mechanism. Here, we study the physicochemical details of mineral nucleation and growth in an animal model that faithfully recapitulates medial arterial calcification in humans, to understand how pathological calcification is initiated on the vascular extracellular matrix. Approach and Results-MGP (matrix Gla protein) is a potent mineralization inhibitor. We study the evolution of medial calcification in MGP-deficient mice over the course of 5 weeks using a combination of material science techniques and find that mineral composition and crystallinity evolve over time and space. We show that calcium is adsorbed first and then amorphous calcium phosphate and octacalcium phosphate forms, which then transform into hydroxyapatite and carbonated apatite. These events are repeated after each nucleation event, providing a snapshot of the overall mineral evolution at each time point analyzed. Conclusions-Our results show that an interdisciplinary approach combining animal models and materials science can provide insights into the mechanism of vascular calcification and suggest the importance of analyzing mineral phases, rather than just overall mineralization extent, to diagnose and possibly prevent disease development. Visual Overview-An online visual overview is available for this article. 
S
ome of the most common pathologies worldwide, such as atherosclerosis, chronic kidney diseases, and type 2 diabetes mellitus involve the calcification of vascular tissues. [1] [2] [3] Vascular calcification is also associated with aging and genetic disorders. 4 Vascular calcification can happen both in the intimal layer of arteries, along with atherosclerotic plaques, or in the medial layer, which is more common in chronic kidney disease and diabetic patients. 1, 5, 6 When arteries calcify, calcium phosphate (Ca-P) minerals are deposited on the extracellular matrix (ECM) of their walls. This process may arise from several different and nonmutually exclusive mechanisms, such as loss of inhibitors, osteochondrogenic transdifferentiation of vascular smooth muscle cells, hyperphosphatemia, hypercalcemia, and cell death. 6, 7 MGP (matrix Gla protein) is one of the most potent mineralization inhibitors that are normally present in the vascular tissues. Luo et al 8 showed that genetically modified mice that do not express MGP develop extensive and progressive medial arterial calcification. Later, Khavandgar et al 9 demonstrated the important role of ELN (elastin) as the main ECM protein regulating mineral deposition in the arteries of these mice and showed that ELN-rich thoracic aorta calcified more extensively than the abdominal aorta, which contains less ELN.
Despite this progress, the physicochemical details of mineral nucleation and growth inside blood vessels are still unknown; this hinders our understanding of how minerals interact with ECM and mineralization inhibitors and of the overall molecular mechanism of vascular calcification.
Several studies have characterized minerals formed in cardiovascular tissues and found that the major inorganic phase is poorly crystalline nonstoichiometric carbonated hydroxyapatite (CHA) with variable Ca/P ratios and substitutions, [10] [11] [12] [13] [14] similar in composition and structure to the mineral component of bone. 15, 16 More recently, other mineral phases were found at early stages of calcification, such as amorphous calcium phosphate (ACP), magnesium-substituted β-tricalcium phosphate (β-TCMP), octacalcium phosphate (OCP), and dicalcium phosphate dehydrate (DCPD). [17] [18] [19] [20] [21] [22] [23] The detection of such phases suggests that the vascular calcification shares common features with bone mineralization; however, a recent study reported the presence of highly crystalline, spherical hydroxyapatite particles in mineralized cardiovascular tissues and, thus, suggested that vascular calcification and bone mineralization follow completely different mechanisms. medial calcification. MGP deficiency in humans causes Keutel syndrome, a rare genetic disease characterized by extensive tissue calcification, pulmonary artery stenosis, brachytelephalangism, and facial dysmorphism. 25 This phenotype is faithfully recapitulated in Mgp −/− mice. Also, in this model, the medial layer of the arteries quickly mineralizes, to the point that the animals die before 2 months of age because of complications caused by extensive mineral deposition. 8 Thus, Mgp −/− mice provides us with a unique in vivo model to study the temporal evolution of medial calcification. We analyze mineral phases and crystallinity by combining traditional spectroscopic and microscopic techniques such as Fourier transform infrared (FTIR) spectroscopy, Raman spectroscopy, x-ray diffraction spectroscopy, energy-dispersive x-ray spectroscopy (EDS), and scanning electron microscopy (SEM), with x-ray photoelectron spectroscopy (XPS) and synchrotron-based spectroscopy. This interdisciplinary approach combining genetically modified mouse models and materials science provides needed insights into the mechanism of ectopic calcification.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Mgp
−/− mice show progressive ectopic deposition of Ca-P minerals along the elastic laminae, reaching highly extensive mineralization after 5 weeks of age ( Figure 1A) . 9 After 5 weeks, at some sites, minerals are also deposited on the surrounding ECM. 26 At a very early stage (5 days), Ca adsorption is sparse in the aorta, and we detect only a punctate pattern primarily in the upper part of the thoracic aorta ( Figure I in the online-only Data Supplement).
Arterial mineral composition in Mgp −/− mice might be influenced by systemic Ca and phosphate levels or abnormal glucose metabolism. However, we did not observe any change in serum Ca and phosphate levels in 5-week-old Mgp −/− mice in comparison to wild-type mice ( Figure 1B) . Also, fasting glucose levels in 1-and 3-week-old Mgp −/− mice did not differ from age-and sex-matched control mice ( Figure 1C ). An initial screening of the type of Ca compounds present in the mouse arteries, their crystallinity, and their amounts can be obtained by FTIR and Raman spectroscopies (Figure 2 ). FTIR spectra of aorta samples from Mgp −/− mice show peaks related to Ca-P phases starting from week 2, which become clearly indicative of hydroxyapatite at week 5 ( Figure 2A ; see the degenerate ν 3 vibration at 1031 and 1091 cm −1 , and the degenerate ν 4 band at 564 and 602 cm −1 ; Table I in the onlineonly Data Supplement). We estimate hydroxyapatite crystallinity by analyzing the relative intensities of the peaks and valleys in the ν 4 envelope (Section 1 in the online-only Data Supplement; Figure IIB in the online-only Data Supplement) and find that the crystallinity of the deposits in 5-week-old mice is comparable to that of bone ( Figure IIA Because the full width at half maximum (FWHM) of the ν 1 phosphate peak inversely correlates with hydroxyapatite crystallinity 27 (Section 1 in the online-only Data Supplement; Figure IIIB in the online-only Data Supplement), we can get a picture of the micron-scale distribution of mineral crystallinity as the mouse age increases ( Figure 2C for the thoracic segment; Figure IVA in the online-only Data Supplement for the abdominal segment). FWHM values are highly heterogeneous in both segments. The median FWHM values decrease in both the thoracic and the abdominal segments as the mice age and reach values that are somewhat higher than those found for hydroxyapatite in mature bone (19.3±0.3 for the minerals found after 5 weeks in the thoracic segment versus 18±0.2 for bone).
By comparing the area underlying the ν 1 phosphate peak between 945 and 962 cm −1 with that of the δ as CH 2 ,CH 3 peak, 28 we can also analyze the changes in inorganic-to-organic ratio, or mineralization extent (ME), as the mouse age increases ( Figure IIIC in the online-only Data Supplement). Similar to FWHM values, the MEs found on aortas from 2-to 5-weekold mice are greatly scattered, suggesting that the mineral distribution on these tissues is highly uneven ( Figure 2D for the thoracic segment; Figure IVB in the online-only Data Supplement for the abdominal segment). At each age analyzed, the median ME in the thoracic segment is significantly higher than that in the abdominal segment from the same mouse (P<0.05), thus confirming that for the same aorta the thoracic part is more calcified than the abdominal one, as expected based on the relative ELN content. 9 Overall, the ME increases as the age of the mice increases in both thoracic and abdominal aortas.
The overall increase in mineral crystallinity over time is further confirmed by x-ray diffraction ( Figure V in mouse age increases, reaching values similar to those found in mature bone. XPS and Ca K-edge near-edge x-ray absorption fine structure (NEXAFS) spectroscopy ( Figure 3 ) provide more details on the chemical composition and Ca-P phases present in the samples. Although only carbon (C), oxygen (O), and nitrogen (N) are present on the XPS survey spectra of wildtype mice aortas ( Figure 3A (i)), the spectra of Mgp −/− mice aortas show also Ca and P ( Figure 3A (ii, iii, iv)), confirming the presence of Ca-P phases in these samples. The Ca and P peaks are visible already after 1 week and increase in intensity in older mice, thus indicating that the mineral amounts increase with time. Indeed, Ca/N ratios are significantly higher in 5-week-old samples than in 3-week-old samples (Table IV in the online-only Data Supplement). The lack of significant differences between 1-and 3-and 3 and 5-weekold samples contrasts with the increasing ME found by Raman spectra. This may be because of the fact that XPS was performed on aorta sections, whereas with Raman spectra, we analyzed whole aortas-thus, Raman spectra results may be more representative.
Ca/P ratios vary greatly among point measurements within samples from the same age and even within the same sample, showing large differences in the composition of the minerals deposited (Table IV in the online-only Data Supplement). Overall, there is a significant increase in the average Ca/P ratios littermates. At 1 wk, the pups were fasted for 2 h, and at 3 wk, the mice were fasted for 4 h. There was no difference in the glucose level between the mutant and control mice at 1 and 3 wk. The Student t test was used for statistical analyses of 2-group comparisons. . Distribution of full width at half maximum (FWHM) values (C) measured on the Raman ν 1 phosphate peak and of mineralization extent (ME; D) based on Raman spectra collected on thoracic aortas from 1-wk-old (gray), 2-wk-old (blue), 3-wk-old (black), 4-wk-old (green), and 5-wk-old (red) Mgp −/− mice. For each age, 3 mice were analyzed, and 20 spectra were collected at different points for each sample.
over time, with values going from 1.5±0.2 after 1 week to 1.8±0.3 after 5 weeks (P<0.05). This increase can be correlated to a change in Ca-P phases 21 ( Figure 3B ; Table V in the online-only Data Supplement). One-week-old aortas contain a larger amount of ACP and OCP than hydroxyapatite, but after 3 weeks, the amounts of ACP and OCP significantly decrease, the amount of hydroxyapatite significantly increases, and CHA appears. After 5 weeks, ACP and OCP further decrease, whereas hydroxyapatite remains constant, and CHA significantly increases ( Figure 3B) .
A more precise identification of both crystalline Ca-P phases and precursors can be achieved with NEXAFS. NEXAFS is a local sensitive and chemically selective probe that is applicable to materials that are crystalline, poorly crystalline, or amorphous. 29 All the reference and arterial sample spectra show 4 features that are typical of Ca-P compounds (Figure VI in the online-only Data Supplement; Figure 3C , respectively). The small feature at the pre-edge (4039 eV) is because of electronic transitions from 1s to 3d orbitals. 30, 31 The most intense absorption, that is, the absorption edge, shows a shoulder peak at 4044 eV, which is assigned to 1s to 4s transitions, and a double peak assigned to 1s to 4p 1/2 and 1s to 4p 3/2 transitions. 30, 31 The relative intensities of the peaks assigned to 1s to 4p 1/2 and 1s to 4p 3/2 transitions depend on the atoms surrounding calcium atoms in the compounds. 30, 31 Features at higher energies are related to transitions from 1s to higher unoccupied states, or multiple scattering contributions. 30, 31 To identify the Ca-P phases present in the samples, we perform linear combination fitting after the procedure explained in Section 1 in the online-only Data Supplement. Table VI in the online-only Data Supplement shows the linear combination fitting results and the R-factors of each fit. All the R-factors are <0.02, thus indicating that all the fits are satisfactory. 32 The results confirm that the calcified aortas are composed of a mixture of hydroxyapatite, CHA, ACP, and OCP. DCPD was not detected in any samples. Although hydroxyapatite and ACP are found as components of the spectra collected on all mice, OCP seems to be present only in the young mice (1 and 2-week-old), whereas CHA only in old mice. −/− mice. Amorphous calcium phosphate (ACP) and octacalcium phosphate (OCP) correspond to Ca/P ratios between 1.3 and 1.5, hydroxyapatite (HA) corresponds to Ca/P ratios between 1.6 and 1.8, and carbonated hydroxyapatite (CHA) corresponds to Ca/P>1.8. For each age, 3 mice were analyzed. For each mouse, 10 Ca/P ratios were determined at different points. One-way ANOVA test was used for statistical analysis followed by Tukey test correction for multiple comparisons.*Significant differences between the different ages, with *P<0.05, **P<0.02, and ***P<0.0001. C, Representative Ca K-edge near-edge x-ray absorption fine structure spectra of calcified aortas from (i) 1-wk-old, (ii) 2-wk-old, (iii) 3-wk-old, (iv) 4-wk-old, and (v) 5-wk-old Mgp −/− mice. D, Relative amounts of precursor phases (ACP and OCP) and apatite phases (CHA and HA) in calcified aortas determined by linear combination fitting based on the reference sample spectra. Five mice were analyzed for each age. The data are averages of 5 values±the SD. One-way ANOVA test was used for statistical analysis followed by Tukey test correction for multiple comparisons. *Significant differences between the different ages, with *P<0.05, **P<0.005, and ***P<0.0001.
To simplify the analysis of mineral evolution over time, we compare the amounts of precursor, nonapatitic Ca-P phases (ie, ACP and OCP), with the amounts of apatitic phases (ie, hydroxyapatite and CHA) at different time points ( Figure 3D ). Larger amounts of precursor phases than apatite are found in 1-week-old mice. After 2 and 3 weeks, the amount of precursors significantly decreases, whereas apatitic phases increase. From 3 to 4 weeks, the composition of the calcified aortas does not significantly change. Finally, in 5-week-old samples, the Ca detected is mainly present in apatitic structures, and only a small amount of ACP can be detected. These results confirm XPS results, showing that although the amount of apatitic phases increases with the age of the mouse, the amounts of precursors decrease. Also, both techniques suggest that the conversion of precursor phases into apatite phases is rather fast in Mgp −/− mice model because a large amount of apatite (33±6% by XPS and 38±6% by NEXAFS) is already present in 1-week-old samples.
Next, we combine micro-x-ray fluorescence and μ-NEXAFS (Figure 4 ) to analyze the spatial distribution of the mineral phases in the thoracic sections of the aortas. Micro-x-ray fluorescence Ca maps ( Figure 4A through 4C) show an uneven mineral distribution. Ca/P ratios calculated based on micro-x-ray fluorescence spectral intensity lie between 1.3 and 1.8 for most of the spots analyzed on 1-and 3-week-old samples (see values reported on Figure 4A and 4B) and between 1.6 and 2.3 for most spots analyzed on 5-week-old samples ( Figure 4C) . Lower values can be seen on the less mineralized areas (values shown in yellow). These results show a conversion from precursor phases to hydroxyapatite and CHA over the course of the 5 weeks of mice life, consistent with XPS.
The areas closer to the abdominal sections (to the left in Figure 4A through 4C) show an overall lower Ca content, which was expected because of the lower ELN content of the abdominal section. 9 On these areas, the Ca/P ratios measured were >4 (values shown in red); this suggests that here Ca ions are only adsorbed on the samples and have yet to be transformed into Ca-P compounds.
μ-NEXAFS Ca K-edge spectra collected on the spots containing the larger amounts of Ca show the presence of OCP, ACP, and hydroxyapatite on the 1-week-old sample, and ACP and hydroxyapatite on the 3-and 5-week-old samples. This observation is consistent with bulk NEXAFS results, which showed the presence of OCP mostly on 1-week-old aortas (Table VI in the online-only Data Supplement).
The locations showing OCP on the 1-week old sample (points (i) through (iii) in Figure 4A and 4D) are close to the abdominal section of the aortas. This observation suggests that the spatial distribution of mineral phases observed on the aortas at a specific time point follows the overall distribution observed with time: the least mineralized points are at earlier transformation stages, whereas the most mineralized points are at later stages. This is further confirmed on 3-and 5-weekold aortas. On the 3-week-old sample, most points analyzed by μ-NEXAFS show higher hydroxyapatite to ACP ratios than the bulk NEXAFS data, because the μ-NEXAFS spectra were collected on the spots showing the highest Ca concentration ( Figure 4E ). On the 5-week-old sample, the differences between μ-NEXAFS and bulk NEXAFS spectra are less evident, because the aorta is overall heavily mineralized; still, even on this sample, the spots that show lower hydroxyapatite to ACP ratios (eg, points (i), (ii), and (iv) in Figure 4F ) are close to the least mineralized areas.
Finally, we combined SEM and EDS to examine the structure of the minerals and their interaction with the ECM. SEM images of calcified aortas from 1-, 3-, and 5-week-old Mgp −/− mice ( Figure 5 ; Figure VII in the online-only Data Supplement) reveal 2 distinct mineral structures: compact material composed of smooth platelets and fibers deposited in networks. These 2 structures were previously reported in cardiovascular calcifications. [12] [13] [14] 21, 24, 33, 34 Elemental analysis by EDS ( Figure VII To further understand the relationship between the minerals and the ECM, we collected EDS maps of elemental distribution ( Figure 6 ). In 1-week-old samples ( Figure 6C through 6G), Ca and P colocalize and are present only along the elastic laminae, in agreement with von Kossa staining ( Figure 6B ). This is confirmed by the SEM/EDS spot analysis ( Figure  VIIIA in the online-only Data Supplement; Table VII in the online-only Data Supplement) and further proves that mineral deposition first occurs on the elastic laminae.
After 5 weeks ( Figure 6J through 6N ), EDS maps show Ca both along and between the elastic laminae, whereas P is mainly present along them, again in agreement with von Kossa staining ( Figure 6I ). This suggests that at some point Ca started being adsorbed between the elastic laminae, whereas P did not.
Discussion
Medial calcification is commonly seen in patients with chronic kidney disease, diabetes mellitus, and some genetic diseases. Because of its rapid and fully penetrant elastic lamina calcification phenotype, Mgp −/− mice have become an attractive model to study medial calcification. Vascular smooth muscle cells, the major cell type present in the arterial media, originate from both neural crest and mesoderm. 35 Regardless of their origin, these cells coordinate the formation of the concentric elastic laminae that are the primary sites of mineral deposition in Mgp −/− mice. Genetic studies have established that arterial elastic content is a critical determinant of vascular calcification. 9 Although earlier studies analyzed the composition of medial calcifications, 19 ,20,24 not much is known on how minerals nucleate, grow, and change in phase and crystallinity; this knowledge could be important in understanding disease development and potentially suggest ways to treat it. In this study, we strive to get to this understanding by analyzing mineral evolution in medial calcifications of Mgp −/− mice over the course of 5 weeks, using a variety of spectroscopic and microscopic techniques. Raman spectroscopy shows that the amount of minerals significantly increases over time and that mineral deposition occurs predominantly on the elastic lamina, an ECM rich The values indicated in A-C are Ca/P ratios based on averaged μ-XRF spectral intensities of 4 pixels. The red cross shown in (B) indicates that the aorta was broken at that location. Ca K-edge micro near-edge x-ray absorption fine structure (μ-NEXAFS) spectra were collected on the spots that contained the highest amounts of Ca (20 pixels per spot), labeled as (i)-(v) in A-C. D-F, Linear combination fitting (LCF) results obtained from the analysis of the Ca K-edge μ-NEXAFS spectra collected at the corresponding locations indicated on the μ-XRF maps, reported along with the LCF results from bulk Ca K-edge spectra on the same samples. ACP indicates amorphous calcium phosphate; and HA, hydroxyapatite.
in ELN, which is more abundant in the thoracic than in the abdominal segment of aortas. 9 Raman, FTIR, and x-ray diffraction spectroscopies show that although the mineral crystallinity is heterogeneous, overall it increases over time. These results confirm previous findings of lower crystallinity in ectopic deposits compared with physiological hard tissues 36 and show that Raman spectra is more reliable than FTIR and x-ray diffraction at evaluating small differences in hydroxyapatite crystallinity. The 3 techniques show that Mgp −/− mice are a model for rapidly progressing medial arterial calcification because in few weeks vascular mineral deposits are almost as crystalline as minerals present in mature bone. 37 Both XPS and NEXAFS allowed us to identify mineral phase transformations. Although NEXAFS provided many more details, XPS was crucial in this study because it was the first time that NEXAFS was applied to the analysis of mineral phase transformations in arterial calcifications, and, thus, a more direct analysis was necessary to validate the results of linear combination fitting deconvolution of NEXAFS spectra.
The mineral phase identification enabled by XPS and NEXAFS confirms previous findings, while providing new insights. Hydroxyapatite and CHA are the most abundant Ca-P phases of both physiological 15, 38 and pathological calcifications. 10, 11, 13, 14 In vitro studies have shown that although hydroxyapatite is the most thermodynamically stable form of Ca-P at physiological pH, different phases can crystallize, and noncrystalline deposits can form too. 39 ACP, OCP, DCPD, and β-TCMP were identified as the main Ca-P phases that can be formed and transformed into hydroxyapatite in vitro. The formation of each phase depends on a combination of pH, temperature, and solution composition. 11 A similar process occurs also in vivo, during bone and enamel formation. 40, 41 In our samples, we did not detect either DCPD or β-TCMP. DCPD is considered a precursor of biological apatite in physiological and in some pathological calcifications, specifically dental and urinary calculi. 11 Recently, few studies have identified DCPD in human valve calcified deposits, 18, 22 but it was never found in arterial calcification. This may be because of different molecular mechanisms involved in arterial and valve calcifications, thus leading to the formation of different precursors of biological apatites. 2, 42 Our study confirms this point. β-TCMP has been reported to be a component of the mineral phase of several soft tissue calcifications, such as dental calculi and salivary stones. 11 In arterial calcification, β-TCMP was detected in addition to hydroxyapatite in both human and rat uremic mineral deposits but not in nonuremic patients. 19, 20 The formation of β-TCMP in uremia-related vascular calcification may potentially be the result of the high concentration of Mg in these patients because of the presence of high levels of Mg ions in the dialysis solution. 11 In rat models of uremiarelated vascular calcification, vitamin D treatment used to induce the calcification stimulates the gastrointestinal absorption of Mg. 19 Because Mgp −/− mice did not receive any treatment that may increase the Mg concentration in their serum, it is not surprising that we did not find β-TCMP in this study.
The finding of ACP in Mgp −/− mice aortas is in line with previous findings showing ACP as the main precursor phase in newly formed bone and enamel, before apatitic phases 16, 40, 41, 43 ; it was also found in both arterial and valve calcification, where it was regarded as a precursor of more crystalline phases. 40, 41, 44 The finding of OCP in arterial calcifications is new. Although previous studies have shown that OCP can be a precursor of biological apatite in normal calcified tissues 45 and in valve calcification, 18, 22 this study reports the presence of OCP in arterial calcification. The high sensitivity of the synchrotron-based techniques we used might explain why we were able to identify OCP in this study. However, the presence of OCP might also be MGP related, and, thus, its formation might be indicative of another molecular mechanism involved. Analyzing the Ca-P phases present in calcified soft tissues from patients with Keutel syndrome may help understand which explanation is the most likely.
Micro-x-ray fluorescence and μ-NEXAFS results suggest that the growth and phase transformation of Ca-P compounds occurs at different times depending on the location of the nucleation and that some locations are less prone to mineralization than others within the same aorta. Thus, by looking at the minerals found at a specific time point, one can get a snapshot of the overall, lifetime mineral phase transformation in the mouse aortas.
SEM/EDS data confirm the crucial role of ELN-rich elastin lamina as the main ECM scaffold onto which minerals deposit in medial arterial calcification. The results also show that while Ca starts accumulating between the elastic laminae after some time, P does not. Vascular calcification may induce both cell death and degradation of the ECM. 7, 9 Dying cells may release Ca from the intracellular storages, whereas degraded ECM may expose Ca-binding peptides (eg, fibrillins), which could serve as substrate for Ca adsorption and, thus, explain the large amount of Ca found. However, the finding that P ions do not initially adsorb on this Ca-rich layer suggests that the substrate onto which Ca is adsorbed crucially determines the rate of mineral nucleation and growth. SEM images did not show any of the highly crystalline hydroxyapatite spheres found in cardiovascular mineral deposits in a previous work. 24 Thus, if any crystalline hydroxyapatite spheres were present in our samples, they would be much less prevalent. This difference may be because of the fact that we analyzed medial arterial calcification, which is associated with ELN, whereas the highly crystalline hydroxyapatite spheres were detected in intimal arterial and valve calcifications. These 2 types of calcification may not necessarily be associated with ELN and may be induced by a different mechanism, that is, chondro-osteogenic transdifferentiation of vascular smooth muscle cells. Thus, this different mechanism and ECM substrate may be responsible for the formation of the highly crystalline spheres, whereas ELN may favor the mineralization process described in this work. Indeed, understanding how different calcification mechanisms affect mineral phase transformation remains to be explored. Thus, it will be important to compare the mineral properties in animal models and human patients with vascular calcification caused by other mechanisms. Overall, our results imply that medial calcification associated with ELN is a multistep process like bone mineralization, starting from amorphous precursors and leading to overall more crystalline deposits. This suggests that an effective strategy to prevent vascular calcification may involve preventing the transformation of metastable precursor phases, which are amorphous or poorly crystalline, into crystalline apatite deposits. Because the metastable precursors are more soluble than hydroxyapatite or CHA, 46 it may be possible to selectively dissolve them with appropriately targeted drugs. This could become a viable treatment for vascular calcifications associated with ELN.
In summary, this study confirms the importance of multidisciplinary approaches combining genetically modified mouse models and material science 24, 44 to unravel the mystery of ectopic mineralization. We show that mineral deposition in medial arterial calcification happens through a precise series of events (adsorption of Ca ions on the elastic lamina, formation of ACP and OCP, and transformation to hydroxyapatite and CHA), which are reproduced after each nucleation event throughout the life of the mice. Although drawn from animal models, these conclusions may be highly relevant to humans as well: analyzing the mineral phases rather than just the overall amount of minerals may help diagnose and possibly prevent disease development. To achieve this, it will be crucial to develop advanced techniques to analyze mineral phase transformation in vivo. [47] [48] [49] 
